Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
NCT02178280
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Hilar Cholangiocarcinoma
Interventions
OTHER:
liver transplantation combined with neoadjuvant therapy
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School